Antogen
United States · Biotech · Healthtech · AI
Antogen provides immunopeptidomics services for drug discovery and translational research, identifying peptide–HLA ligands in biological samples.
Mapping the signals recognized by the immune system
Antogen is a life sciences tools and diagnostics company serving pharmaceutical teams, biotechnology companies and medical researchers. Its immunopeptidomics services identify and quantify peptides presented by HLA molecules in tissue, biopsies, cell lines and blood samples.
Researchers use these results to discover disease-associated targets, assess candidate therapies and support patient-selection strategies. Antogen combines proteomics, biological datasets and machine learning, including a healthy-tissue reference library that helps teams investigate potential off-target effects. Its commercial work includes contract research services while it develops broader immune-surveillance applications.
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | Undisclosed | iGrow Venture Partners — Lead |